25
Participants
Start Date
June 27, 2019
Primary Completion Date
June 3, 2022
Study Completion Date
June 2, 2024
Ascorbate
"Phase 1 dose escalation:~75gm IV three times a week~Phase II portion:~75gm IV three times a week if no dose limiting toxicities are experienced in the Phase I portion. Otherwise, ascorbate dose will be deescalated to 62.5 gm IV"
University of Iowa Hospitals and Clinics, Iowa City
University of Iowa
OTHER
Mohammed Milhem
OTHER